✦ LIBER ✦

A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study

✍ Scribed by J. Russell Geyer; Frank M. Balis; Mark D. Krailo; Richard Heideman; Emmett Broxson; Judith K. Sato; David Poplack; W. Archie Bleyer

Publisher: Springer US
Year: 1995
Tongue: English
Weight: 436 KB
Volume: 13
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00873141

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of carboplatin in child

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the childrens cancer group

✍ Lawrence J. Ettinger; Paul S. Gaynon; Mark D. Krailo; Ning Ru; Edward S. Baum; S 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 3 views

Background. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity than

A phase II study of ifosfamide in childr

A phase II study of ifosfamide in children with recurrent solid tumours

✍ C. R. Pinkerton; H. Rogers; C. James; A. Bowman; P. R. H. Barbor; O. B. Eden; J. 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 457 KB

Carboplatin in childhood brain tumors: A

Carboplatin in childhood brain tumors: A children's cancer study group phase II trial

✍ Paul S. Gaynon; Lawrence J. Ettinger; Edward S. Baum; Stuart E. Siegel; Mark D. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 3 views

Phase II study of daily oral etoposide i

Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors

✍ Needle, Michael N.; Molloy, Patricia T.; Geyer, J. Russell; Herman-Liu, Alisa; B 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 2 views

Pre-clinical data and adult experience suggests that topoisomerase targeted anti-cancer agents may be highly schedule dependent, and efficacy may improve with prolonged exposure. To investigate this hypothesis, 28 children with recurrent brain and solid tumors were enrolled in a phase II study of or

Phase I study of CI-958 in children and

Phase I study of CI-958 in children and adolescents with recurrent solid tumors

✍ Carola A. S. Arndt; Mark D. Krailo; Wen Liu-Mares; Peter M. Anderson; Gregory H. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

BACKGROUND. CI-958 is a synthetic intercalating agent of a new chemical class, the benzopyranoindazoles, with promising preclinical activity. Its mechanism of action is thought to be stabilization of the cleavable complex of DNA with topoisomerase II, as well as DNA helicase blockade. It is thought

Phase II investigation of docetaxel in p

Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors : A report from the Children's Oncology Group

✍ Ted Zwerdling; Mark Krailo; Philip Monteleone; Rebecca Byrd; Judith Sato; Rose D 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND Docetaxel, which is an antitubulin agent, has demonstrable activity against murine and human tumors. The current study was designed to determine response rates to docetaxel in various strata of recurrent solid tumors of childhood and to assess toxicity in a group of patie